Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Generic Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (164)
Cancellation by sponsor (126)
Prescription medicine registration (10)
Cancellation or suspension (7)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (4)
2025 (13)
2024 (26)
2023 (23)
2022 (32)
2021 (15)
2020 (19)
2019 (24)
2018 (33)
2017 (17)
2016 (14)
2015 (10)
2014 (7)
2013 (13)
2012 (12)
2011 (17)
2010 (1)
2009 (6)
2008 (6)
2007 (13)
2006 (1)
2004 (2)
2001 (3)

Search

Sponsor content

311 result(s) found, displaying 141 to 150

ESCITALOPRAM GH escitalopram (as oxalate) 10 mg tablet blister (292295)

23 February 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ESCITALOPRAM GH escitalopram (as oxalate) 10 mg tablet blister.
CON-TGO91-157 - Generic Health Pty Ltd

30 July 2020

Section 14, TGO91 consent

Product(s) approved for Supply with noncompliant labelling.
METFORMIN GENERICHEALTH metformin hydrochloride 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
Electrolyte Rehydration Solution Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
Pharmacy Action Electrolyte Rehydration Solution Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
PHARMACY ACTION Hayfever & Sinus Pain Relief PE tablets blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
PHARMACY ACTION Calmative Pain Relief tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
VENLAFAXINE SANDOZ XR venlafaxine (as hydrochloride) 150mg modified release capsule blister Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
VENLAFAXINE SANDOZ XR venlafaxine (as hydrochloride) 75mg modified release capsule blister Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd
METFORMIN GENERICHEALTH 1000 metformin hydrochloride 1000 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Generic Health Pty Ltd

Pages

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Current page 15
Page 16
Page 17
Page 18
Page 19
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.